Anthony Thatcher

Anthony Thatcher has over 20 years of experience in pharmaceuticals and biotechnology. His experience spans two launches of commercial products and work on both autologous and allogenic cell therapies. He also has experience with viral and tissue-based therapies. Anthony is a collaborative, results-driven Biotechnology leader with a proven record of successful technology transfers and bringing new therapies to market. He holds a B.S. in Biology from Gonzaga University and an M.B.A. with a focus on Supply Chain from Rutgers Business School. He is currently the Senior Director of Manufacturing Operations at Sumitomo Pharma America. Anthony has supported publications in validation handbooks as well as presenting in a variety of cell and tissue therapy conferences. He also serves as a member of the ISPE ATMP Community of Practice Steering Committee.